DK0810868T3 - Anvendelse af piperidin som et biotilgængelighedsforøgende middel - Google Patents

Anvendelse af piperidin som et biotilgængelighedsforøgende middel

Info

Publication number
DK0810868T3
DK0810868T3 DK95939489T DK95939489T DK0810868T3 DK 0810868 T3 DK0810868 T3 DK 0810868T3 DK 95939489 T DK95939489 T DK 95939489T DK 95939489 T DK95939489 T DK 95939489T DK 0810868 T3 DK0810868 T3 DK 0810868T3
Authority
DK
Denmark
Prior art keywords
piperidine
compositions
bioavailability enhancer
piperine
nutrients
Prior art date
Application number
DK95939489T
Other languages
English (en)
Inventor
Muhammed Majeed
Vladimir Badmaev
R Jayanagar Rajendran
Original Assignee
Sabinsa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27014435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0810868(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/393,738 external-priority patent/US5536506A/en
Application filed by Sabinsa Corp filed Critical Sabinsa Corp
Application granted granted Critical
Publication of DK0810868T3 publication Critical patent/DK0810868T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
    • A23L27/11—Natural spices, flavouring agents or condiments; Extracts thereof obtained by solvent extraction
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
DK95939489T 1995-02-24 1995-11-06 Anvendelse af piperidin som et biotilgængelighedsforøgende middel DK0810868T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/393,738 US5536506A (en) 1995-02-24 1995-02-24 Use of piperine to increase the bioavailability of nutritional compounds
US08/550,496 US5744161A (en) 1995-02-24 1995-10-30 Use of piperine as a bioavailability enhancer
PCT/US1995/012758 WO1996025939A1 (en) 1995-02-24 1995-11-06 Use of piperine as a bioavailability enhancer

Publications (1)

Publication Number Publication Date
DK0810868T3 true DK0810868T3 (da) 2001-11-26

Family

ID=27014435

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95939489T DK0810868T3 (da) 1995-02-24 1995-11-06 Anvendelse af piperidin som et biotilgængelighedsforøgende middel

Country Status (12)

Country Link
US (2) US5744161A (da)
EP (1) EP0810868B1 (da)
JP (1) JP3953513B2 (da)
AT (1) ATE204757T1 (da)
AU (1) AU4128796A (da)
CA (1) CA2247467C (da)
DE (1) DE69522477T2 (da)
DK (1) DK0810868T3 (da)
ES (1) ES2161914T3 (da)
GR (1) GR3036711T3 (da)
PT (1) PT810868E (da)
WO (1) WO1996025939A1 (da)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352713B1 (en) * 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
US6488956B1 (en) * 1994-06-20 2002-12-03 Drugtech Corporation Multi-vitamin and mineral supplements for women
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
US6060060A (en) * 1997-01-31 2000-05-09 Bmb Patent Holding Corporation Analgesic compositions from sweet peppers and methods of use thereof
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
WO1999007387A1 (en) 1997-08-08 1999-02-18 Nutrition 21 Chromium/biotin treatment of type ii diabetes
US5789401A (en) * 1997-08-08 1998-08-04 Nutrition 21 High-dose chromium/biotin treatment of type II diabetes
GB9815177D0 (en) 1998-07-13 1998-09-09 King S College London Treatment of skin disorders
GB2370989A (en) 2001-01-16 2002-07-17 Btg Int Ltd Piperine analogues for the treatment of skin conditions
US6680391B2 (en) 1998-07-13 2004-01-20 Btg International Limited Treatment of skin conditions
WO2000015051A1 (en) * 1998-09-14 2000-03-23 Interhealth Nutraceuticals, Inc. Hydroxycitric acid compositions
US6376549B1 (en) 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
CA2344246A1 (en) 1998-09-17 2000-03-23 Akesis Pharmaceuticals, Inc. Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
US6086888A (en) * 1998-12-22 2000-07-11 Bmb Patent Holding Corporation Analgesic compositions from sweet bell peppers and methods of use thereof
US6054585A (en) * 1998-12-23 2000-04-25 Sabinsa Corporation Process for making high purity piperine for nutritional use
US6534086B1 (en) * 2000-03-06 2003-03-18 Metagenics, Inc. Composition and method for treatment of inflammation and pain in mammals
US6258846B1 (en) * 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements
US7112609B2 (en) * 1999-06-01 2006-09-26 Drugtech Corporation Nutritional supplements
US6187333B1 (en) * 1999-09-20 2001-02-13 Diabex, Inc. Method for treating, controlling, and preventing diabetes mellitus
US20030236300A1 (en) * 1999-10-27 2003-12-25 Yale University Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
DE10196213T1 (de) * 2000-05-19 2003-04-30 Sabinsa Corp Verfahren erhöhter Bioverfügbarkeit von Nährstoffen und pharmazeutische Präparationen mit Tetrahydropiperin und Analoga und Derivaten davon
RU2002107449A (ru) * 2000-06-26 2003-11-20 Бакулиш Мафатлал ХАМАР (IN) Хемосенсибилизатор
AU2001267856A1 (en) * 2000-06-28 2002-01-08 Kikkoman Corporation Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same
AU2001287743A1 (en) * 2000-09-20 2002-04-02 R.P. Scherer Gmbh And Co. Kg Oral dosage forms of boswellia extracts
JP4858889B2 (ja) * 2000-10-20 2012-01-18 有限会社大長企画 栄養剤、消化器剤
US6576253B2 (en) * 2000-12-05 2003-06-10 Pbm Pharmaceuticals, Inc. Food bars containing nutritional supplements
US20040043013A1 (en) 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US6579866B2 (en) * 2000-12-28 2003-06-17 Mccleary Larry Composition and method for modulating nutrient partitioning
US20060062864A1 (en) * 2000-12-28 2006-03-23 Mccleary Edward L Weight loss composition and method
IT1320180B1 (it) * 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e
US6689400B2 (en) * 2001-01-30 2004-02-10 Sabinsa Corporation Process of obtaining compositions of stable lutein and lutein derivatives
WO2002090515A2 (en) * 2001-05-04 2002-11-14 Theralife, Inc. Compositions and methods for reducing cytotoxicity and inhibiting angiogenesis
WO2003028747A1 (en) * 2001-10-04 2003-04-10 Harris Dennis H Ingestible nerve and circulatory nutritional formulation
US20030099626A1 (en) * 2001-11-20 2003-05-29 Health Education Corporation Nutrient absorption enhancing compositions and methods
US20030170326A1 (en) * 2001-12-13 2003-09-11 Council Of Scientific And Industrial Research Bioavailability enchancing activity of Zingiber officinale Linn and its extracts/fractions thereof
EP1489924A2 (en) * 2002-03-12 2004-12-29 Council Of Scientific And Industrial Research Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
AU2003214505A1 (en) * 2002-04-04 2003-10-20 Bakulesh Khamar Process for preparation of pharmaceutical composition containing antiretroviral protease inhibitor with improved bioavailability
US6979468B1 (en) 2002-12-06 2005-12-27 Sirius Laboratories Oral composition and method for the treatment of inflammatory cutaneous disorders
AU2003202112A1 (en) * 2003-01-30 2004-08-23 Council Of Scientific And Industrial Research Bioavailability enhancing activity of carum carvi extracts and fractions thereof
EP1608370A1 (en) 2003-03-31 2005-12-28 Council of Scientific and Industrial Research Use of cuminum cyminum extract and piperine for potention of bioeffiacy of anti infectives
US7160565B2 (en) * 2003-03-31 2007-01-09 Breakthru Products, Llc Hydration beverage and method of delivering nutrients
US7119075B2 (en) * 2003-03-31 2006-10-10 Council Of Scientific And Industrial Research Use of herbal agents for potentiation of bioefficacy of anti infectives
US8703209B2 (en) * 2003-06-17 2014-04-22 Edward Larry McCleary Composition and method for modulating hydrogen ion physiology
EP1875816A3 (en) * 2003-07-10 2008-03-12 Carl A. Forest Beverages with specialized supplements
JP4012894B2 (ja) * 2003-09-17 2007-11-21 レキオファーマ株式会社 ウコン含有組成物
JP4797363B2 (ja) * 2003-11-13 2011-10-19 大正製薬株式会社 高血圧改善剤
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
EP1719519B1 (de) * 2005-02-24 2007-10-24 PM-International AG Nahrungsergänzungsmittelpräparat-Set
US20060198906A1 (en) * 2005-03-07 2006-09-07 Sami Labs Limited Compositions and Method to Increase Serum Levels of HDL cholesterol and Lower the Risk of Cardiovascular Disease
US8021701B1 (en) 2005-04-13 2011-09-20 Perry Stephen C Composition to retard the onset of symptoms of alzheimer's disease
FR2887748B1 (fr) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires.
FR2887749B1 (fr) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires
DE102005043986A1 (de) * 2005-09-14 2007-04-05 Mark Warnecke Zusatznahrungsmittel
EP1940816A2 (en) * 2005-09-30 2008-07-09 OMP, Inc. Stable ascorbic acid compositions
US20070116852A1 (en) * 2005-11-22 2007-05-24 Josef Schnatmann Cattle feed preparation
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
ES2579229T3 (es) 2007-03-13 2016-08-08 Jds Therapeutics, Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
EP2011495A1 (en) * 2007-07-03 2009-01-07 Sygnis Bioscience GmbH & Co. KG Use of piperine and derivatives thereof for the therapy of neurological conditions
US7877929B2 (en) 2007-08-04 2011-02-01 Rezzorb, Llc Method and apparatus for reducing fertilizer use in agricultural operations
US20090062231A1 (en) * 2007-08-31 2009-03-05 O'mara Ann Marie Appetite Suppressant Composition and Method of Appetite Suppression
US20090297622A1 (en) * 2008-01-01 2009-12-03 Khorshid Faten A Separation and formulation of bioactive fraction and subfraction from camel urine work as anticancer agent
KR101078376B1 (ko) * 2009-02-02 2011-10-31 연세대학교 산학협력단 피페린 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 예방 및 치료용 조성물
US8247435B2 (en) * 2009-02-19 2012-08-21 Thornthwaite Jerry T Formulations for treating human and animal diseases
US20100273207A1 (en) * 2009-04-24 2010-10-28 Raymond Langley Methods for Diagnosis of Sepsis and Risk of Death
ES2547466T3 (es) 2009-06-17 2015-10-06 Fatin A. Khorshid Separación y formulación de fracción bioactiva y trabajo de subfracción de orina de camello como agente anticáncer
EP2289528A1 (en) 2009-07-21 2011-03-02 DSM IP Assets B.V. Novel nutraceutical compositions containing black pepper or its constituents improving mental performance
WO2011010214A1 (en) * 2009-07-23 2011-01-27 Cadila Pharmaceuticals Ltd. Pharmaceutical composition of rifampicin
JP2011073973A (ja) * 2009-09-29 2011-04-14 Shiseido Co Ltd 更年期のための疲労改善組成物
GB201002314D0 (en) * 2010-02-11 2010-03-31 Gomez Richard N C Dietary supplement composition
GB201002318D0 (en) * 2010-02-11 2010-03-31 Gomez Richard N C Dietary supplement composition
JP2012051833A (ja) * 2010-08-31 2012-03-15 Toyo Shinyaku Co Ltd 血流改善用組成物
JP2012070726A (ja) * 2010-08-31 2012-04-12 Toyo Shinyaku Co Ltd バイオアベイラビリティを高めた美容食品用組成物
KR101281827B1 (ko) * 2011-03-25 2013-07-03 (주)풀무원홀딩스 피페린을 유효성분으로 포함하는 인삼 사포닌 흡수 촉진용 조성물
US8840938B2 (en) * 2011-04-13 2014-09-23 W. Matthew Warnock Bioavailability enhancing composition
US9168308B2 (en) * 2011-04-22 2015-10-27 Paul Joseph FAERSTEIN Compositions and methods for nutritional supplementation
WO2013108254A1 (en) 2012-01-19 2013-07-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Formulation and method for increasing oral bioavailability of drugs
WO2013165455A1 (en) 2012-05-01 2013-11-07 Rutgers, The State University Of New Jersey Production of enriched products
JP6760710B2 (ja) * 2013-09-13 2020-09-23 大正製薬株式会社 飲料
AU2014342214B2 (en) 2013-11-01 2020-05-21 Rutgers, The State University Of New Jersey Extracts from plants of the Moringaceae family and methods of making
WO2016164224A1 (en) 2013-11-01 2016-10-13 Rutgers, The State University Of New Jersey Extracts from plants of the moringaceae family and methods of making
US11865121B2 (en) 2016-02-11 2024-01-09 Nutrition21, LLC Chromium containing compositions for improving health and fitness
IT201600128994A1 (it) * 2016-12-20 2018-06-20 Inpha Duemila Srl Formulazioni per uso nel trattamento dell’endometriosi e dei disturbi ad essa associati
EP3621617A1 (en) 2017-05-12 2020-03-18 Innovus Pharmaceuticals, Inc. Therapeutic methods and compositions
PT3651805T (pt) 2017-07-11 2023-12-22 Aquanova Ag Solubilizado com curcumina e, pelo menos, uma substância ativa adicional
US11267798B2 (en) 2017-10-14 2022-03-08 Cipla Limited Process for the preparation of piperine
US10864205B2 (en) * 2017-12-01 2020-12-15 Innovus Pharmaceuticals, Inc. Nutritional supplement for improving sexual health in men and women
US10758505B2 (en) * 2017-12-01 2020-09-01 Innovus Pharmaceuticals, Inc. Therapeutic compositions and methods
US10500199B2 (en) 2017-12-01 2019-12-10 Innovus Pharmaceuticals, Inc. Nutritional supplement for increasing cognitive functions
US20190167699A1 (en) 2017-12-01 2019-06-06 Innovus Pharmaceuticals, Inc. Prostate function support formula
DE102018101778A1 (de) * 2018-01-26 2019-08-01 Lts Lohmann Therapie-Systeme Ag Mehrschichtiger Oraler Dünnfilm
FI3820527T3 (en) 2018-07-11 2023-09-28 Aquanova Ag XANTHOHUMOL CELL BILISATE
WO2020081357A1 (en) * 2018-10-16 2020-04-23 Golden Spice Liquors LLC Beverage compositions and methods of making and using the same
US10849948B2 (en) 2019-04-16 2020-12-01 The Procter & Gamble Company Supplement for menopause
FR3097122B1 (fr) * 2019-06-11 2021-06-18 Valbiotis Melange d’extraits de plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l’intestin
IL271778A (en) 2019-12-31 2021-06-30 Ichilov Tech Ltd Methods for treating atopic dermatitis
UA128422C2 (uk) * 2020-05-29 2024-07-03 Ведісіналс Індіа Прайвіт Лімітед Композиція для лікування covid-19 і пов'язаних з ним розладів
JP2020196770A (ja) * 2020-09-16 2020-12-10 株式会社東洋新薬 血流改善剤
JP7162357B2 (ja) * 2020-10-02 2022-10-28 株式会社山田養蜂場本社 桂皮酸誘導体の吸収促進剤
JP2021066739A (ja) * 2021-01-28 2021-04-30 株式会社東洋新薬 血流改善組成物
JP2024526812A (ja) * 2021-07-22 2024-07-19 ニコベンチャーズ トレーディング リミテッド カンナビスの成分、誘導体又は抽出物を含む組成物
CN116268431B (zh) * 2022-12-22 2025-06-27 北京康比特体育科技股份有限公司 一种改善或促进乳清蛋白吸收的组合物及其应用
CN116602405B (zh) * 2023-05-18 2024-05-28 北京康比特体育科技股份有限公司 含黑胡椒提取物的组合物在制备促进肌肉蛋白质合成及缓解和/或消除炎症的产品中的应用
CN117958426A (zh) * 2024-01-31 2024-05-03 武汉森澜生物科技有限公司 含荜茇和黑胡椒的营养素生物利用度促进剂和制备方法
JP2025132995A (ja) * 2024-02-29 2025-09-10 株式会社三旺コーポレーション 経口用組成物
CN118766020A (zh) * 2024-08-21 2024-10-15 馨辰生物(广东)有限公司 润肠通便饮品及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284657A (en) * 1980-01-09 1981-08-18 Kraf, Inc. Fluidized oleoresin compositions
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer

Also Published As

Publication number Publication date
JP3953513B2 (ja) 2007-08-08
US5972382A (en) 1999-10-26
GR3036711T3 (en) 2001-12-31
PT810868E (pt) 2002-02-28
DE69522477T2 (de) 2002-05-29
ATE204757T1 (de) 2001-09-15
US5744161A (en) 1998-04-28
DE69522477D1 (de) 2001-10-04
JPH11500725A (ja) 1999-01-19
CA2247467C (en) 2007-05-29
WO1996025939A1 (en) 1996-08-29
EP0810868A1 (en) 1997-12-10
EP0810868A4 (en) 1998-11-25
AU4128796A (en) 1996-09-11
EP0810868B1 (en) 2001-08-29
CA2247467A1 (en) 1996-08-29
ES2161914T3 (es) 2001-12-16

Similar Documents

Publication Publication Date Title
DK0810868T3 (da) Anvendelse af piperidin som et biotilgængelighedsforøgende middel
BG103268A (en) Propionic acid derivatives and their application
AP9701019A0 (en) Phenylamino-substituted tricycle derivatives.
HUT68357A (en) Heterocyclic-cyclic-amine derivatives, pharmaceutical compositions containing them and process for their production
AU6114699A (en) Naphthrydine compounds and their azaisosteric analogues as antibacterials
HUT61289A (en) Process for producing pyrimidine derivatives of sulfonamides and pharmaceutical compositions comprising same
MY126069A (en) Anticancer compound and enantiomer separation method useful for synthesizing said compound
ATE399171T1 (de) Camptothecinanaloge und deren zubereitungsmethoden
HUT56494A (en) Process for producing pharmaceutical compositions suitable for peroral administration of pimobendane
ZA961074B (en) Chiral Methylphenyloxazolidinones.
IT1255792B (it) Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
CA2412047A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
ATE382050T1 (de) Buprenorphinesterderivate, verfahren zu ihrer herstellung, und langwirksame analgetische arzneimittel
MXPA02012182A (es) Medicamentos para la terapia de demencias.
AU2003271811A1 (en) Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same
AU7624398A (en) New substituted tetrahydropyridine compounds, process for preparing them and pharmaceutical compositions containing them
DK1242067T3 (da) Calciumformiat som et kosttilskud
IL135364A0 (en) Vitamin d derivatives, processes for the production thereof and for producing pharmaceutical compositions containing the same
AU2003227717A1 (en) 17Alpha-FLUOROALKYL-11Beta-BENZALDOXIME-STEROIDS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAID STEROIDS AND THE USE THEREOF IN THE PRODUCTION OF MEDICAMENTS
HUP9800707A2 (hu) Fenoximetil-piperidin-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
DK1091001T3 (da) Fremgangsmåde til rensning af S-adenosyl-L-methionin og til fremstilling af farmaceutiske acceptable salte deraf
HUP0201281A3 (en) (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
PL356523A1 (en) Substituted 1 and 2 naphthol mannich bases